Utility of the CapsoCam Plus for Overt Gastrointestinal Bleeding After Negative Gastroscopy: A Retrospective Cohort Study
Gastroenterology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/grp/1813362 ↗Abstract
Introduction Patients with upper gastrointestinal bleeding have a nondiagnostic gastroscopy if bleeding is distal to the duodenum. Capsule endoscopy can localise bleeding to anywhere in the gastrointestinal tract; yield is highest when performed as soon as possible, although impaired motility in unwell patients reduces complete examination rate. The CapsoCam Plus operates without external support equipment, and has a long battery life, theoretically improving completion rate and diagnostic yield. Objectives The objectives were to determine the examination completion rate (to the caecum), diagnostic yield and impact on management of the CapsoCam Plus in patients with suspected acute upper gastrointestinal bleeding and nondiagnostic gastroscopy. Methods This was an observational retrospective cohort study of patients who underwent gastroscopy within 24 hours of admission to Sheffield Teaching Hospitals, with suspected upper gastrointestinal bleeding. Capsule endoscopy using the CapsoCam Plus was performed in those in whom gastroscopy was normal or identified lesions of uncertain significance. A single expert video reader identified and localised blood, pathological lesions, completeness of small bowel examination and duration of examination. Data were collected retrospectively, including the nature of bleeding, type and timing of investigations, management and diagnosis. Results A median of 9 days (IQR 5–14 days) after bleeding, 113 capsule endoscopies were performed in 106 patients (62 M, median age 72 (IQR 63–79) years). Examination was complete to the caecum in 96.5% of cases. Capsule endoscopy identified pathology, blood (in the upper gastrointestinal tract [5.6%], small bowel [68.4%], colon [24.1%] or throughout [1.9%]) or both in 54 (47.8%) examinations, guiding further investigation in 30 (55.6%) of these cases. Of the total number of examinations, capsule endoscopy alone or following guided investigation led to new diagnoses in 21 (18.6%, mostly in the small bowel) and therapeutic intervention in 18 (15.9%). Conclusions CapsoCam capsule endoscopy had a high completion rate, making new diagnoses in 18.6% of patients and altering management in the majority of this subgroup.
EUVIMED